ADXN NASDAQ
Addex Therapeutics Ltd
1W: -15.9%
1M: -12.8%
3M: -47.0%
YTD: -62.0%
1Y: -67.3%
3Y: -56.4%
5Y: -98.4%
$3.07
+0.09 (+3.02%)
Weekly Expected Move ±14.6%
$2
$3
$3
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$5M
+32.8% ▲
Capital Expenditures
$1K
+81.4% ▲
5Y CAGR: -46.3%
Free Cash Flow
-$5M
+32.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$524K
+83.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$13M | -$15M | -$21M | -$11M | $7M |
| Depreciation & Amort. | $379K | $348K | $323K | $306K | $260K |
| Stock-Based Comp. | $1M | $1M | $4M | $2M | $0 |
| Change in Working Capital | -$2M | -$762K | $158K | $214K | -$1M |
| Other Non-Cash Items | $973K | $33K | $204K | $250K | -$11M |
| Operating Cash Flow | -$12M | -$15M | -$16M | -$8M | -$5M |
| — Investing Activities — | |||||
| Capital Expenditures | -$59K | -$32K | -$581 | -$7K | -$1K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$473K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $1K | $4K | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $5M |
| Investing Cash Flow | -$59K | -$30K | $3K | -$7K | $5M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$367K | -$310K | -$288K | -$282K | -$74K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$306K | $3M | $2M | $3M | -$62K |
| Financing Cash Flow | $46K | $16M | $3M | $5M | $105K |
| Net Change in Cash | -$13M | $2M | -$14M | -$3M | -$524K |
| Cash End of Period | $19M | $20M | $7M | $4M | $3M |
| Free Cash Flow | -$12M | -$15M | -$16M | -$8M | -$5M |